Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 03:42:45 +0200Wed, 12 Jun 2024 15:11:00 +0200Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 12, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ozempicHuman medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 12, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ozempicWed, 12 Jun 2024 15:11:00 +0200Human medicineOzempic : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/ema-other-h-4174-en.pdfOzempic : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/ema-other-h-4174-en.pdfWed, 12 Jun 2024 02:00:00 +0200Human medicine